These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 15458529

  • 1. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
    Moehrle M, Schippert W, Rassner G, Garbe C, Breuninger H.
    Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.
    Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039
    [Abstract] [Full Text] [Related]

  • 4. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.
    Ann Surg Oncol; 2007 Dec 28; 14(12):3566-74. PubMed ID: 17924169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
    Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ.
    Ann Surg Oncol; 2006 Jul 28; 13(7):927-32. PubMed ID: 16788753
    [Abstract] [Full Text] [Related]

  • 11. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.
    Arch Dermatol; 2005 Aug 28; 141(8):1016-22. PubMed ID: 16103331
    [Abstract] [Full Text] [Related]

  • 12. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.
    Cancer; 2001 Jun 15; 91(12):2401-8. PubMed ID: 11413531
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
    Möhrle M, Schippert W, Rassner G, Garbe C, Breuninger H.
    Dermatology; 2004 Jun 15; 209(1):5-13. PubMed ID: 15237261
    [Abstract] [Full Text] [Related]

  • 17. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
    Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, Bertsch HP, Kretschmer L.
    J Dtsch Dermatol Ges; 2008 Mar 15; 6(3):198-203. PubMed ID: 18093216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.
    Eur J Surg Oncol; 2008 Jan 15; 34(1):82-8. PubMed ID: 17360144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.